Richards, Merrill & Peterson’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Richards, Merrill & Peterson's BMY Position: Q3 2026 in Review
Richards, Merrill & Peterson reduced its Bristol-Myers Squibb (BMY) stake by 4.2% in Q3 2026, selling an estimated $17.1K and leaving 6,129 shares worth $382K. The position accounts for 0.12% of the portfolio, ranked #142.
Richards, Merrill & Peterson first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. The position peaked at $448K in Q1 2025. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Richards, Merrill & Peterson held 6,129 shares of Bristol-Myers Squibb worth $382K as of Q3 2026.
- Richards, Merrill & Peterson sold 271 Bristol-Myers Squibb shares in Q3 2026, an estimated $17.1K.
- Bristol-Myers Squibb made up 0.12% of Richards, Merrill & Peterson's portfolio in Q3 2026, its #142 holding.
- Richards, Merrill & Peterson first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
- Richards, Merrill & Peterson's Bristol-Myers Squibb position peaked at $448K in Q1 2025.
- 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Richards, Merrill & Peterson's 13F filing for Q3 2026, filed 19 Oct 2026.